The Enterprise Value as of April 2026 (TTM) for X4 Pharmaceuticals, Inc. (XFOR) is -93503343.00

According to X4 Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is -93503343.00. This represents a change of -162.61% compared to the average of 149.34M of the last 4 quarters.

X4 Pharmaceuticals, Inc. (XFOR) Historical Enterprise Value (quarterly & annually)

How has XFOR Enterprise Value performed in the past?

The mean historical Enterprise Value of X4 Pharmaceuticals, Inc. over the last ten years is 40.12M. The current -93503343.00 Enterprise Value has changed -23408.51% with respect to the historical average. Over the past ten years (40 quarters), XFOR's Enterprise Value was at its highest in in the December 2025 quarter at 302.46M. The Enterprise Value was at its lowest in in the December 2017 quarter at -50404118.40.

X4 Pharmaceuticals, Inc. (XFOR) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of X4 Pharmaceuticals, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

X4 Pharmaceuticals, Inc. (XFOR) Average Enterprise Value

How has XFOR Enterprise Value performed in the past?

The current Enterprise Value of X4 Pharmaceuticals, Inc. (XFOR) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

X4 Pharmaceuticals, Inc. (XFOR) Enterprise Value vs. Peers

How is XFOR’s Enterprise Value compared to its peers?

X4 Pharmaceuticals, Inc.’s Enterprise Value is less than Aligos Therapeutics, Inc. (25.26M), less than Karyopharm Therapeutics Inc. (244.82M), less than FibroGen, Inc. (-19341848.00), less than Mersana Therapeutics, Inc. (91.27M), less than Kezar Life Sciences, Inc. (-15555565.00), less than Senti Biosciences, Inc. (37.42M), less than INmune Bio, Inc. (12.17M), less than Skye Bioscience, Inc. (24.43M), less than OnKure Therapeutics, Inc. (11.64M), less than Tempest Therapeutics, Inc. (8.43M),

Build a custom stock screener for X4 Pharmaceuticals, Inc. (XFOR) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like X4 Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

X4 Pharmaceuticals, Inc. (XFOR) and other stocks custom spreadsheet templates

The easiest way to analyze a company like X4 Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.